study	individual	group	count	intervention	measurement_type	substance	tissue	method	time	time_unit	value	unit	comments
Han2009a	cyp2c9_1_1_S1	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	8.65265944605836	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S1	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.54180602006689	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S2	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	7.43192366010518	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S2	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	3.28873572447041	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S3	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	6.21118787415201	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S3	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.67223628188401	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S4	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	4.75633837582425	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S4	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.90634999425859	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S5	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	4.63928151963696	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S5	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	3.78483382926416	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S6	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	3.08409305235709	ng/ml*hr	NA
Han2009a	cyp2c9_1_1_S6	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.64214046822742	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S1	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	3.61920558842171	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S1	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.03455964325529	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S2	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.71062141896797	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S2	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.30211817168339	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S3	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.66602833089662	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S3	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.22965892435902	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S4	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.1699257053113	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S4	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	2.38573021181716	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S5	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.63480864845511	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S5	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.5886287625418	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S6	NA	1.0	LOS50	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.06624677554541	ng/ml*hr	NA
Han2009a	cyp2c9_1_3_S6	NA	1.0	LOS50, SIL140	auc_ratio	exp3174/losartan	plasma	HPLC MS	24.0	hr	1.0200668896321	ng/ml*hr	NA
